Table 3. Antibiotic susceptibility profile of multidrug-resistant non-fermenting Gram-negative bacilli.
| Antimicrobial agents (mcg) | Pseudomonas aeruginosa (%) | Acinetobacter baumannii (%) | Acinetobacter lwoffii (%) | Acinetobacter haemolyticus (%) | Burkholderia cepacia complex (%) | Stenotrophomonas maltophilia (%) |
| Amikacin (30) | 44% | 28.7% | 15.5% | 17.6% | - | |
| Ceftazidime (30) | 16.7% | 6.9% | 4.8% | 2.9% | 28.6% | - |
| Ciprofloxacin (5) | 32% | 19.0% | 21.4% | 11.8% | - | - |
| Gentamicin (10) | 43.8% | 31.6% | 23.8% | 20.6% | - | - |
| Imipenem (10) | 33.3% | 20.7% | 10.7% | 14.7% | - | - |
| Meropenem (10) | 56.6% | 23.0% | 11.9% | 8.8% | 42.9% | - |
| Piperacillin-tazobactam (100/10) | 34.1% | 20.7% | 20.2% | 14.7% | - | - |
| Minocycline (30) | - | 64.4% | 60.7% | 64.7% | 100% | 27.3% |
| Cotrimoxazole (25) | - | - | - | - | 28.6% | 36.4% |
| Ampicillin- sulbactam (10/10) | - | 45% | 41.6% | 41.1% | - | - |
| Levofloxacin (5) | - | - | - | - | - | 27.3% |